Traditional Chinese medicinal preparation for treating gout disease

Abstract

The invention relates to a traditional Chinese medicinal preparation for treating a gout disease. The traditional Chinese medicinal preparation is prepared from the following raw materials: semen plantaginis, indian iphigenia bulb, prepared radix aconiti, rhizoma corydalis, dandelion, prepared nux vomica, folium artemisiae argyi, phryma leptostachya, roasted tortoise plastron, prepared rhizoma arisaematis, clematis root, homalomena occulta, herba artemisiae scopariae, alisma, honey-fried licorice root. The traditional Chinese medicinal preparation disclosed by the invention has the effects of dispelling wind, clearing heat, inducing diuresis and reducing edema, relieve rheumatic pains, warming the middle part and Yang, tonifying spleen, dissipating cold, invigorating the circulation of blood, performing analgesic therapy, dispelling wind and removing obstruction in the meridians; after administration, the preparation can terminate attack of acute arthritis as soon as possible, relieve pain, inhibit synthesis of uric acid, promote excretion of uric acid, correct hyperuricemia, restrain damage to the kidneys as the urate is settled in the kidneys and joints, inhibit formation of uric acid crystals in the kidneys, recover and improve metabolism, facilitate removal of vivotoxin, prevent and treat diabetes, hypertension, dyslipidemia and other complications, thoroughly relieve local redness, fever, swelling, pain and other symptoms in the body, and finally effectively control and cure the gout disease.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine preparation for treating gout. Background technique [0002] Gout is a recurrent disease caused by increased purine biosynthesis and metabolism, excessive uric acid production or poor excretion of uric acid, resulting in elevated uric acid in the blood, and deposition of urate crystals in the synovium, synovial bursa, cartilage and other tissues. Episodic inflammatory disease. It is a group of heterogeneous diseases caused by monosodium urate crystallization or supersaturation of uric acid in extracellular fluid, resulting in the deposition of crystals in tissues. The disease is characterized by birefringent sodium urate monohydrate crystals found in joint fluid and tophi. Its clinical features are: characteristic acute arthritis, tophi, and interstitial nephritis caused by hyperuricemia and urate crystallization and deposition, which ...

AI Technical Summary

Problems solved by technology

[0004] Modern medicine generally treats gout according to the acute phase, intermittent phase and chronic phase. Commonly used drugs have colchicine, phenylbutazone, indomethacin, ibuprofen, etc., but these drugs have defects, and most of them can only stabilize the disease. The disease cannot be cured, and it will cause serious side effects and damage the liver and kidney functions; even if the recent treatment is effective, the recurrence of the disease cannot be controlled, and drug resistance and resistance may occur, and even leukopenia, impaired heart function, Impaired liver and kidney function, irritated gastrointestinal system and other comorbidities, and gout has the characteristics of recurrent attacks, it is difficult for patients to accept long-term use of western medicine